AMM 352: Ozempic Effect: Tackling ‘Ozempic Face’ Trends with Galderma Solutions
February 10, 2025
This episode explores the dermatological trend of ‘Ozempic face,’ prompted by the widespread use of the weight loss drug, Ozempic. Listeners will learn about the facial changes associated with significant weight loss and how dermal fillers are providing solutions. The episode also delves into the UK cosmetic injectables market, revealing surprising statistics about who performs these procedures and discussing the growing role of dentists in facial aesthetics. Tune in for insights into the evolving landscape of aesthetic medicine and the regulatory challenges it presents.
Quick Takes
- Ozempic, a weight loss drug, is causing unwanted changes in facial appearance dubbed ‘Ozempic face’
- ‘Ozempic face’ includes sagging, shadowing, and loss of volume in the face
- Dermal fillers are suggested as a solution for addressing the changes caused by ‘Ozempic face’
Episode Transcript
Today, February 10, 2025, we’re diving into a growing trend in dermatology, driven by the widespread use of the weight loss drug, Ozempic. Made by Novo Nordisk, Ozempic simulates the feeling of fullness, helping users reduce their food intake without hunger. However, as people shed pounds, some are experiencing unwanted changes in their facial appearance—lovingly dubbed ‘Ozempic face.’
This phenomenon is characterized by sagging, shadowing, and loss of volume, largely due to reductions in fat, collagen, elastin, and essential fatty acids. To address these changes, Galderma suggests dermal fillers as a viable solution. Clinical investigator Michael Somenek highlights the positive impact fillers can have on mid-face contouring, cheek wrinkles, and overall facial appearance. A study showed that 89% of those using fillers felt more attractive and satisfied with their looks.
Interestingly, a good portion of cosmetic injections in the UK aren’t carried out by doctors. According to a study led by plastic surgeon David Zargaran, 24% of these procedures are done by dentists and 8% by dental nurses. Surprisingly, 12% of injectables are administered by non-healthcare ‘aestheticians,’ highlighting a regulatory challenge in the cosmetic injectables market.
Stay tuned with us for more insightful updates in the world of aesthetic medicine.